-
Luna's Lunar Leap: Grabs $50M Investment To Fuel Silixa Buyout & More
Thursday, December 21, 2023 - 1:40pm | 379Luna Innovations Inc (NASDAQ: LUNA) disclosed a strategic investment of $50 million from White Hat Capital Partners. The company will partially use the proceeds to fund the acquisition of Silixa, which was announced today, for $21.5 million in upfront cash consideration and up to an...
-
Monogram Orthopedics' Surgical Robot Now Reality As Company Delivers First System
Thursday, December 7, 2023 - 9:15am | 965Robotic surgeries are going mainstream for a good reason: they make it easier for doctors to perform complex surgeries. Monogram Orthopedics Inc. (NASDAQ: MGRM), which aims to revolutionize orthopedic joint replacement surgery with its robotic technology, just got one step closer to achieving that...
-
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
Monday, November 13, 2023 - 1:18pm | 302Moleculin Biotech Inc (NASDAQ: MBRX) provided a preliminary update on recent clinical activity from annamycin lead development programs. Annamycin is the company's next-generation anthracycline that has been designed to be non-cardiotoxic (unlike currently prescribed anthracyclines)...
-
Why Is Neurocrine Biosciences Stock Trading Lower Today?
Friday, November 10, 2023 - 2:43pm | 380Thursday, Neurocrine Biosciences Inc (NASDAQ: NBIX) released Phase 2 study results from two signal-seeking pipeline programs in focal onset seizures and anhedonia. The investigational selective NaV 1.6 inhibitor, NBI-921352, licensed from Xenon Pharmaceuticals Inc (...
-
Why Is Neurocrine Biosciences Shares Trading Higher Today?
Thursday, October 5, 2023 - 2:38pm | 252Neurocrine Biosciences Inc (NASDAQ: NBIX) released topline data from the Phase 3 CAHtalyst Pediatric Study of crinecerfont in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. CAH is an inherited condition that affects...
-
Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary
Tuesday, September 19, 2023 - 1:15pm | 344Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) entered into a merger agreement under which its subsidiary, Pelican Technology Holdings Inc, has become a wholly owned subsidiary of Primrose Bio Inc. Primrose Bio is a stand-alone private company focused on synthetic biology....
-
GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday
Wednesday, September 13, 2023 - 8:45am | 566Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in pre-market trading. Goldman Sachs slashed Ultrapar Participações S.A. (NYSE: UGP)...
-
What's Going On With Neurocrine Biosciences Stock Today?
Tuesday, September 12, 2023 - 2:33pm | 295Neurocrine Biosciences Inc (NASDAQ: NBIX) announced positive topline data from the Phase 3 CAHtalyst Adult Study evaluating crinecerfont in adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD). CAH is a group of genetic conditions limiting...
-
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
Monday, August 21, 2023 - 2:24pm | 549The FDA approved Neurocrine Biosciences Inc's (NASDAQ: NBIX) Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated with Huntington's disease (HD). Ingrezza is the only selective vesicular monoamine transporter 2 (VMAT2) inhibitor that offers an...
-
Gaia And 2 Other Stocks Under $4 Insiders Are Buying
Tuesday, August 8, 2023 - 8:50am | 519The Dow Jones closed lower by over 400 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision....
-
Why Are Novan Shares Nosediving Today?
Monday, July 17, 2023 - 10:25am | 417Novan Inc (NASDAQ: NOVN) shares are trading lower after Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has offered to acquire the company's assets. The deal value includes $15 million in cash and provides up to $15 million in DIP financing to Novan,...
-
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Thursday, July 13, 2023 - 12:49pm | 1519Gainers Synaptogenix, Inc. (NASDAQ: SNPX) gained 85.5% to $1.6291. Synaptogenix abstract highlighting Bryostatin-1 benefits in severe Alzheimer's disease accepted for presentation at 11th International Brain Research Organization World Congress Of Neuroscience. Jiuzi Holdings, Inc. (NASDAQ:...
-
Confidence Boost From Ingrezza Sales: Analyst Upgrades Neurocrine Biosciences
Thursday, July 6, 2023 - 3:12pm | 426BMO Capital Markets has upgraded Neurocrine Biosciences Inc (NASDAQ: NBIX) from Underperform to Market Perform, with a price target of $96, up from $91. The upgrade follows BMO's recent proprietary survey of 25 psychiatrists treating patients with tardive dyskinesia, a...
-
TransCode Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying
Friday, June 23, 2023 - 7:08am | 495The Dow Jones closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is...
-
Lexicon Pharmaceuticals And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
Wednesday, June 21, 2023 - 8:56am | 486The Dow Jones closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision....